Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 268158201 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Deep Track Capital, LP
13G/A
Amendment 3
|
0% |
2/11/2026
Event 2/10/2026
|
|
| Deep Track Capital, LP | 0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 0% | ||
| David Kroin | 0% | ||
|
Deep Track Capital, LP
13G/A
Amendment 2
|
13.4% |
8/25/2025
Event 8/22/2025
|
|
| Deep Track Biotechnology Master Fund, Ltd. | 13.4% | ||
| Deep Track Capital, LP | 13.4% | ||
| David Kroin | 13.4% | ||
| BlackRock, Inc. 13G/A Amendment 6 | 14.2% |
7/17/2025
Event 6/30/2025
|
|
|
Deep Track Capital, LP
13D/A
Amendment 2
|
13.5% |
2/19/2025
Event 2/18/2025
|
|
| Deep Track Biotechnology Master Fund, Ltd. | 13.5% | ||
| Deep Track Capital, LP | 13.5% | ||
| David Kroin | 13.5% | ||
|
Kynam Capital Management, LP
13G/A
Amendment 1
|
4.99% |
2/14/2025
Event 12/31/2024
|
|
| Kynam Capital Management, LP | 4.99% | ||
| Kynam Capital Management GP, LLC | 4.99% | ||
| Yue Tang | 4.99% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 1 | 6.00 | $93.00 |
| 2025 Q4 | 281 | 112 M | $1.73 B |
| 2025 Q3 | 288 | 115 M | $1.14 B |
| 2025 Q2 | 279 | 116 M | $1.15 B |
| 2025 Q1 | 299 | 128 M | $1.66 B |
| 2024 Q4 | 273 | 131 M | $1.67 B |
| 2024 Q3 | 265 | 130 M | $1.45 B |
| 2024 Q2 | 249 | 135 M | $1.52 B |
| 2024 Q1 | 264 | 139 M | $1.73 B |
| 2023 Q4 | 256 | 133 M | $1.85 B |
| 2023 Q3 | 236 | 126 M | $1.86 B |
| 2023 Q2 | 224 | 127 M | $1.64 B |
| 2023 Q1 | 224 | 128 M | $1.26 B |
| 2022 Q4 | 252 | 128 M | $1.36 B |
| 2022 Q3 | 257 | 116 M | $1.21 B |
| 2022 Q2 | 229 | 118 M | $1.49 B |
| 2022 Q1 | 227 | 102 M | $1.10 B |
| 2021 Q4 | 229 | 97.3 M | $1.37 B |
| 2021 Q3 | 208 | 96.9 M | $1.86 B |
| 2021 Q2 | 174 | 89.8 M | $885 M |
| 2021 Q1 | 185 | 83.9 M | $823 M |
| 2020 Q4 | 164 | 73.9 M | $329 M |
| 2020 Q3 | 185 | 88.1 M | $380 M |
| 2020 Q2 | 171 | 80.7 M | $716 M |
| 2020 Q1 | 128 | 65.6 M | $231 M |
| 2019 Q4 | 135 | 67.3 M | $385 M |
| 2019 Q3 | 130 | 67.7 M | $242 M |
| 2019 Q2 | 149 | 54.7 M | $218 M |
| 2019 Q1 | 157 | 53.6 M | $394 M |
| 2018 Q4 | 153 | 54.5 M | $498 M |
| 2018 Q3 | 171 | 48.9 M | $607 M |
| 2018 Q2 | 177 | 52.6 M | $802 M |
| 2018 Q1 | 158 | 52.1 M | $1.03 B |
| 2017 Q4 | 157 | 46.9 M | $877 M |
| 2017 Q3 | 143 | 45.9 M | $987 M |
| 2017 Q2 | 132 | 36.0 M | $348 M |
| 2017 Q1 | 117 | 30.4 M | $179 M |
| 2016 Q4 | 139 | 27.2 M | $107 M |
| 2016 Q3 | 154 | 31.7 M | $332 M |
| 2016 Q2 | 136 | 32.3 M | $479 M |
| 2016 Q1 | 140 | 33.6 M | $645 M |
| 2015 Q4 | 170 | 31.6 M | $770 M |
| 2015 Q3 | 156 | 32.8 M | $805 M |
| 2015 Q2 | 128 | 26.7 M | $626 M |
| 2015 Q1 | 103 | 26.2 M | $587 M |
| 2014 Q4 | 80 | 18.0 M | $303 M |
| 2014 Q3 | 4 | 10.7 M | $15.4 M |